Aardvark Therapeutics announced the FDA has lifted the clinical hold on its drug ARD-101, intended to treat hyperphagia in Prader-Willi Syndrome (PWS). Exploratory data from previous trials showed ARD-101 reduced hunger scores more than placebo and was generally well tolerated. The company plans to meet with the FDA in early 2027 to discuss the clinical development plan and expects to resume clinical activities that year. With $60.3 million in cash, Aardvark is financially positioned to support operations through 2027.
Aardvark Therapeutics' third quarter 2026 update is presented here with Pluang's Health sector market data as of Nov 13, 2026 19:41 WIB. Among 150 priced Health-sector US stocks tradable on Pluang, 99 rose and 43 fell today. Notable movers include MMED at USD 17.00 with a 1-day change of -4.90%, CTXR at USD 0.51 with a 1-day change of -4.21% and a Pluang order activity of 84% Sell / 16% Buy, and TNGX at USD 24.00 with a 1-day change of -3.42%.
Michelin has announced the total number of its voting rights and shares as of October 31, 2026. The company has 691,516,292 shares and 960,075,649 voting rights, considering 20,287,710 treasury shares. This disclosure complies with French regulations...
Michelin has disclosed the total number of voting rights and shares composing its capital as of October 31, 2026. The company reported 691,516,292 shares, with theoretical voting rights totaling 980,363,359 and exercisable voting rights at 960,075,64...
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
